查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493196

体外诊断品管市场规模、份额和趋势分析报告：按产品类型、按应用、按製造商类型、按最终用途、按地区和细分趋势：2024-2030

In Vitro Diagnostics Quality Control Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By Manufacturer Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 185 Pages | 商品交期: 2-10个工作天内

价格

体外诊断品管市场成长与趋势：

根据Grand View Research, Inc.最新报告，到2030年，全球体外诊断品管市场规模预计将达到15.9亿美元，2024年至2030年复合年增长率为3.2%。

诊断领域不断发展的以技术为导向的变化以及确保患者安全的日益增长的需求使得必须在多个医疗领域实施品质保证计划，包括照护现场设备和放射学。由于患者依赖自检体外诊断 (IVD) 设备进行长期疾病管理，因此确保此类 IVD 设备结果的可重复性和有效性对于确保患者安全至关重要，因此从这一点检查品质非常重要。

越来越多的经认可的临床实验室提供可靠的基于 IVD 的诊断服务，这是市场成长的推动力，因为它直接转化为患者信心的提高。多重PCR常规诊断的主要病原体包括HIV、HSV（脑膜炎和脑炎）、流感嗜血桿菌、肺炎链球菌（呼吸道感染疾病）、淋病奈瑟菌和沙眼衣原体（生殖器感染疾病）、兰巴迪亚衣原体、沙眼利什曼原虫症。除了评估之外，还对法规结构进行间歇性修订，以加强现行标准，主要目的是保障向患者提供的诊断服务的品质卓越。

实验室的品管重点是确保向患者提供的结果准确。控制测试通常在仪器安装期间、维护后、试剂批次变更或仪器读数不在范围内时进行。居家照护环境包括用于在患者床边进行测试的各种护理点 (PoC) 设备、检测套组以及医疗保健支援环境中的体外诊断 (IVD) 设备。自检检测套组对于需要常规检测的患者来说很方便，可以进一步减少就诊次数。

体外诊断品管市场报告亮点

  • 2023年，临床化学领域占最大市场份额。对预防医学的需求不断增长以及临床实验室迅速转变为高度自动化和高效的企业是导致高市场占有率的因素。
  • 品管领域预计将在 2023 年占据市场主导地位，并在市场估计和预测期内以最高复合年增长率成长。实验室的品管重点是证明提供给个人的结果是准确的。
  • 由于基于次世代定序(NGS)、质谱、微阵列等先进技术的设备以及优化品管程序的应用不断增加，医院细分市场将在 2023 年占据最大份额。
  • 许多製药公司正在实施美国FDA 制定的新指南草案，以确保现行良好生产规范 (cGMP) 的资料完整性。
  • 本指南提供了与建立健全的操作程序和强大的控制系统、获取高品质原材料、调查偏差以及维护可靠的诊断实验室相关的资讯。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 配套市场前景
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
    • 机会分析
    • 供应链分析
  • 营商环境分析
    • PESTEL分析
    • 波特五力分析

第四章体外诊断品管市场：依产品細項分析，2018-2030

  • 体外诊断品管市场：产品变异分析
  • 体外诊断品管市场估计与预测：按产品
  • 控制
  • 校准器
  • 其他的

第五章体外诊断品管市场：按类型細項分析，2018-2030

  • 体外诊断品管市场：类型变异分析
  • 体外诊断品管市场估计与预测：按类型
  • 品管
  • 品质保证服务
  • 资料管理解决方案

第六章 体外诊断品管市场：依应用估算与趋势分析

  • 体外诊断品管市场：应用变异分析
  • 体外诊断品管市场估计与预测：按应用
  • 免疫化学
  • 血液学
  • 临床化学

第七章体外诊断品管市场：按製造商类型估计和趋势分析

  • 体外诊断品管市场：製造商类型变异分析
  • 体外诊断品管市场估计和预测：按製造商类型
  • 第三方管理
  • OEM管理

第八章体外诊断品管市场：最终用途估计与趋势分析

  • 体外诊断品管市场：最终用途变异分析
  • 按最终用途分類的体外诊断品管市场估计和预测
  • 医院
  • 实验室
  • 居家照护
  • 其他的

第 9 章 体外诊断品管市场：区域估计与趋势分析，按产品、类型、应用、製造商类型、最终用途

  • 体外诊断品管市场：区域展望
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第10章竞争格局

  • 公司分类
  • 参与企业概况
  • 财务绩效
  • 产品基准
    • 2023 年体外诊断品管市场占有率分析
    • 2023 年等离子控制设备企业市场占有率
    • 2023 年以血清为基础的对照品企业市场占有率
    • 2023 年全血对照试验中的企业市场占有率
  • 策略规划
    • 併购
    • 伙伴关係与协作
    • 扩张
    • 产品核准和上市
    • 其他的

第十一章 公司简介

  • 公司分类
  • 参与企业概况
    • Siemens Healthineers AG
    • Abbott
    • Bio-Rad Laboratories, Inc.
    • Danaher
    • F. Hoffmann-La Roche Ltd
    • Sysmex Corporation
    • QuidelOrtho Corporation
    • Randox Laboratories Ltd
    • Helena Laboratories Corporation
    • Thermo Fisher Scientific, Inc.
    • SeraCare Life Sciences, Inc.
    • BD
    • Merck KGaA
    • QIAGEN
    • Hologic, Inc.
    • Bio-Techne
    • Fortress Diagnostics
    • Microbiologics
    • TRINA BIOREACTIVES AG
    • ConeBioproducts
    • Biorex Diagnostics
  • 财务绩效
  • 产品基准
Product Code: 978-1-68038-925-8

In Vitro Diagnostics Quality Control Market Growth & Trends:

The global in vitro diagnostics quality control market size is expected to reach USD 1.59 billion by 2030, registering a CAGR of 3.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The continually evolving technology-oriented changes in the diagnostics field and the growing requirement to ensure patient safety necessitate the execution of quality assurance programs in several medical domains including point-of-care devices and radiology.The patients rely on self-testing in vitro diagnostics (IVD) devices for long-term disease management and hence it is important for such IVD devices to be checked for quality in terms of result reproducibility and validity to guarantee patient safety.

The rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving market growth. Some of the key pathogens routinely diagnosed using multiplex PCR, but not limited to, are HIV, HSV (meningitis and encephalitis), H. influenza, S. pneumonia (respiratory tract infections), N. gonorrhea, C. trachoma (genital infections), G. lambardia, C. parvum (diarrheal diseases), and Leishmaniaspp (Leishmaniasis).In addition to assessments, amendments to the regulatory framework are made intermittently to enhance the present standards with the main objective of safeguarding the qualitative superiority of the diagnostic services rendered to patients.

Quality control in the laboratory is focused on ensuring that the results delivered to the patient are accurate. Control checks are usually undertaken while installing an instrument, after servicing, changing reagent lots, and when the instrument readings are not in range.Home care settings include a variety of devices, such as point-of-care (PoC) instruments used for near-patient bed testing, self-testing kits, and IVD devices in assisted healthcare settings. Self-testing kits giveease of convenience for patients who require everyday testing and further reduce hospital visits.

In Vitro Diagnostics Quality Control Market Report Highlights:

  • In 2023, the clinical chemistry segment held the largest share of the market. The increasing demand for preventive medicine and the rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors responsible for its high market share
  • The quality control segment dominated the market in 2023 and is estimated to grow at the highest CAGR over the forecast period. Quality control in the research laboratory is concentrated on certifying the results provided to the individuals are precise
  • The hospital segment held the largest share in 2023 due to the presence of highly advanced technology-based devices, such as Next Generation Sequencing (NGS), mass spectrophotometry, and microarrays, and the rising applications of the optimized quality-control procedures
  • Many pharmaceutical companies are implementing the new draft guidance enforced by the U.S. FDA for data integrity on current Good Manufacturing Practices (cGMP)
  • It provides information in relation to establishing robust operating procedures and strong management systems, obtaining high-quality raw materials, investigating deviations, and maintaining reliable diagnostic laboratories

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Regional scope
    • 1.1.2. Market definitions
    • 1.1.3. Estimates and forecasts timeline
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
      • 1.7.1.2. Approach 2: Country wise market estimation using bottom-up approach.
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. By Product and Type Segment Snapshot
  • 2.3. By application and Manufacturer Type Segment Snapshot
  • 2.4. By End-use Segment Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising number of accredited clinical laboratories
      • 3.2.1.2. Increasing third-party quality control services
      • 3.2.1.3. Presence of favorable regulatory bodies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of IVD quality control services
      • 3.2.2.2. Unfavorable reimbursement scenario in IVD industry
    • 3.2.3. Opportunity analysis
    • 3.2.4. Supply chain analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. PESTEL analysis
    • 3.3.2. Porter's five forces analysis

Chapter 4. In Vitro Diagnostics Quality Control Market: Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 4.1. In Vitro Diagnostics Quality Control Market: Product movement Analysis
  • 4.2. In Vitro Diagnostics Quality Control Market Estimates & Forecast, by Product (USD Million)
    • 4.2.1. Controls
      • 4.2.1.1. Total protein
      • 4.2.1.2. Albumin
      • 4.2.1.3. Blood urea nitrogen
      • 4.2.1.4. Uric acid
      • 4.2.1.5. Creatinine
      • 4.2.1.6. Sodium
      • 4.2.1.7. Potassium
      • 4.2.1.8. Chloride
      • 4.2.1.9. Calcium
      • 4.2.1.10. Magnesium
      • 4.2.1.11. Inorganic phosphorus
      • 4.2.1.12. Aspartate transaminase
      • 4.2.1.13. Creatine kinase
      • 4.2.1.14. Gamma glutamyl transferase
      • 4.2.1.15. Total bilirubin
      • 4.2.1.16. C-Reactive Protein
      • 4.2.1.17. Glucose
      • 4.2.1.18. Iron
      • 4.2.1.19. Alanine transaminase
      • 4.2.1.20. Alkaline phosphatase
      • 4.2.1.21. Alpha-amylase
      • 4.2.1.22. Total cholesterol
      • 4.2.1.23. Triglyceride
      • 4.2.1.24. Lactate dehydrogenase
      • 4.2.1.25. Immunoglobulin G
      • 4.2.1.26. Immunoglobulin A
      • 4.2.1.27. Immunoglobulin M
      • 4.2.1.28. Complement 3
      • 4.2.1.29. Complement 4
      • 4.2.1.30. Rheumatoid factor
      • 4.2.1.31. Anti-Streptolysin -O
      • 4.2.1.32. Beta 2 microglobulin
      • 4.2.1.33. Cystatin-C
      • 4.2.1.34. Myoglobin
      • 4.2.1.35. Troponin T and I
      • 4.2.1.36. Others
    • 4.2.2. Calibrators
    • 4.2.3. Others

Chapter 5. In Vitro Diagnostics Quality Control Market: Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 5.1. In Vitro Diagnostics Quality Control Market: Type Movement Analysis
  • 5.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by Type (USD Million)
    • 5.2.1. Quality Controls
      • 5.2.1.1. Plasma-based control
      • 5.2.1.2. Serum-based control
      • 5.2.1.3. Whole blood-based Control
      • 5.2.1.4. Others
    • 5.2.2. Quality Assurance Services
    • 5.2.3. Data Management Solutions

Chapter 6. In Vitro Diagnostics Quality Control Market: By Application Estimates & Trend Analysis

  • 6.1. In Vitro Diagnostics Quality Control Market: Application Movement Analysis
  • 6.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by Application (USD Million)
  • 6.3. Immunochemistry
  • 6.4. Hematology
  • 6.5. Clinical Chemistry
      • 6.5.1.1. Alkaline Phosphatase (ALP)
      • 6.5.1.2. Alanine Transaminase (ALT)
      • 6.5.1.3. Aspartate Transaminase (AST)
      • 6.5.1.4. Creatine Kinase MB (CK-MB)
      • 6.5.1.5. Albumin
      • 6.5.1.6. Creatinine
      • 6.5.1.7. Glucose
      • 6.5.1.8. Triglycerides
      • 6.5.1.9. Amylase
      • 6.5.1.10. Others
    • 6.5.2. Molecular diagnostics
    • 6.5.3. Coagulation
    • 6.5.4. Microbiology
    • 6.5.5. Others

Chapter 7. In Vitro Diagnostics Quality Control Market: By Manufacturer Type Estimates & Trend Analysis

  • 7.1. In Vitro Diagnostics Quality Control Market: Manufacturer Type Movement Analysis
  • 7.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by Manufacturer Type (USD Million)
    • 7.2.1. Third-party controls
      • 7.2.1.1. Independent controls
      • 7.2.1.2. Instrument specific controls
    • 7.2.2. OEM controls

Chapter 8. In Vitro Diagnostics Quality Control Market: End-use Estimates & Trend Analysis

  • 8.1. In Vitro Diagnostics Quality Control Market: End-use Movement Analysis
  • 8.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by End-use (USD Million)
    • 8.2.1. Hospitals
    • 8.2.2. Laboratories
    • 8.2.3. Home care
    • 8.2.4. Others

Chapter 9. In Vitro Diagnostics Quality Control Market: Regional Estimates & Trend Analysis, by Product, Type, Application, Manufacturer Type, and End-use

  • 9.1. In Vitro Diagnostics Quality Control Market: Regional Outlook
  • 9.2. North America
    • 9.2.1. North America in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key country dynamics
      • 9.2.2.2. U.S. in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.2.2.3. Competitive/ market scenario
      • 9.2.2.4. Regulatory framework
    • 9.2.3. Canada
      • 9.2.3.1. Key country dynamics
      • 9.2.3.2. Canada in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.2.3.3. Competitive/ market scenario
      • 9.2.3.4. Regulatory framework
  • 9.3. Europe
    • 9.3.1. Europe in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. UK in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.2.3. Competitive/ market scenario
      • 9.3.2.4. Regulatory framework
    • 9.3.3. Germany
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Germany in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.3.3. Competitive/ market scenario
      • 9.3.3.4. Regulatory framework
    • 9.3.4. France
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. France in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.4.3. Competitive/ market scenario
      • 9.3.4.4. Regulatory framework
    • 9.3.5. Italy
      • 9.3.5.1. Key country dynamics
      • 9.3.5.2. Italy in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.5.3. Competitive/ market scenario
      • 9.3.5.4. Regulatory framework
    • 9.3.6. Spain
      • 9.3.6.1. Key country dynamics
      • 9.3.6.2. Spain in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.6.3. Competitive/ market scenario
      • 9.3.6.4. Regulatory framework
    • 9.3.7. Denmark
      • 9.3.7.1. Key country dynamics
      • 9.3.7.2. Denmark in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.7.3. Competitive/ market scenario
      • 9.3.7.4. Regulatory framework
    • 9.3.8. Sweden
      • 9.3.8.1. Key country dynamics
      • 9.3.8.2. Sweden in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.8.3. Competitive/ market scenario
      • 9.3.8.4. Regulatory framework
    • 9.3.9. Norway
      • 9.3.9.1. Key country dynamics
      • 9.3.9.2. Norway in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.9.3. Competitive/ market scenario
      • 9.3.9.4. Regulatory framework
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Japan in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.4.2.3. Competitive/ market scenario
      • 9.4.2.4. Regulatory framework
    • 9.4.3. China
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. China in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.4.3.3. Competitive/ market scenario
      • 9.4.3.4. Regulatory framework
    • 9.4.4. India
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. India in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.4.4.3. Competitive/ market scenario
      • 9.4.4.4. Regulatory framework
    • 9.4.5. Australia
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Australia in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.4.5.3. Competitive/ market scenario
      • 9.4.5.4. Regulatory framework
    • 9.4.6. Thailand
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Thailand in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.4.6.3. Competitive/ market scenario
      • 9.4.6.4. Regulatory framework
    • 9.4.7. South Korea
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. South Korea in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.4.7.3. Competitive/ market scenario
      • 9.4.7.4. Regulatory framework
  • 9.5. Latin America
    • 9.5.1. Latin America in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Brazil in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.5.2.3. Competitive/ market scenario
      • 9.5.2.4. Regulatory framework
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Mexico in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.5.3.3. Competitive/ market scenario
      • 9.5.3.4. Regulatory framework
    • 9.5.4. Argentina
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Argentina in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.5.4.3. Competitive/ market scenario
      • 9.5.4.4. Regulatory framework
  • 9.6. MEA
    • 9.6.1. MEA in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. South Africa in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.6.2.3. Competitive/ market scenario
      • 9.6.2.4. Regulatory framework
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Saudi Arabia. in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.6.3.3. Competitive/ market scenario
      • 9.6.3.4. Regulatory framework
    • 9.6.4. UAE
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. UAE in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.6.4.3. Competitive/ market scenario
      • 9.6.4.4. Regulatory framework
    • 9.6.5. Kuwait
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Kuwait in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.6.5.3. Competitive/ market scenario
      • 9.6.5.4. Regulatory framework

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Participant's Overview
  • 10.3. Financial Performance
  • 10.4. Product Benchmarking
    • 10.4.1. In vitro diagnostics quality control market share analysis, 2023
    • 10.4.2. Company market share, 2023 for plasma-based controls
    • 10.4.3. Company market share, 2023 for serum-based controls
    • 10.4.4. Company market share, 2023 for whole blood-based controls
  • 10.5. Strategy Mapping
    • 10.5.1. Mergers & acquisitions
    • 10.5.2. Partnerships & collaborations
    • 10.5.3. Expansion
    • 10.5.4. Product approval & launch
    • 10.5.5. Others

Chapter 11. Company Profiles

  • 11.1. Company Categorization
  • 11.2. Participant's Overview
    • 11.2.1. Siemens Healthineers AG
    • 11.2.2. Abbott
    • 11.2.3. Bio-Rad Laboratories, Inc.
    • 11.2.4. Danaher
    • 11.2.5. F. Hoffmann-La Roche Ltd
    • 11.2.6. Sysmex Corporation
    • 11.2.7. QuidelOrtho Corporation
    • 11.2.8. Randox Laboratories Ltd
    • 11.2.9. Helena Laboratories Corporation
    • 11.2.10. Thermo Fisher Scientific, Inc.
    • 11.2.11. SeraCare Life Sciences, Inc.
    • 11.2.12. BD
    • 11.2.13. Merck KGaA
    • 11.2.14. QIAGEN
    • 11.2.15. Hologic, Inc.
    • 11.2.16. Bio-Techne
    • 11.2.17. Fortress Diagnostics
    • 11.2.18. Microbiologics
    • 11.2.19. TRINA BIOREACTIVES AG
    • 11.2.20. ConeBioproducts
    • 11.2.21. Biorex Diagnostics
  • 11.3. Financial Performance
  • 11.4. Product Benchmarking

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 In vitro diagnostics quality control market revenue estimates and forecast, by product, 2018 - 2030 (USD Million)
  • Table 4 In vitro diagnostics quality control market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • Table 5 In vitro diagnostics quality control market revenue estimates and forecast, by application, 2018 - 2030 (USD Million)
  • Table 6 In vitro diagnostics quality control market revenue estimates and forecast, by manufacturer type, 2018 - 2030 (USD Million)
  • Table 7 In vitro diagnostics quality control market revenue estimates and forecast, by end-use, 2018 - 2030 (USD Million)
  • Table 8 The classification of levels of IVD in South Africa
  • Table 9 Company market share, 2023

List of Figures

  • Fig. 1 In vitro diagnostics quality control market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Product and type segment snapshot
  • Fig. 11 Application and manufacturer type segment snapshot
  • Fig. 12 End-use segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 In vitro diagnostics market value, 2023 (USD Billion)
  • Fig. 15 Market dynamics
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 In vitro diagnostics quality control market: Product outlook and key takeaways
  • Fig. 19 In vitro diagnostics quality control market: Product movement analysis
  • Fig. 20 Controls market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Controls market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 22 Total protein estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Total protein market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 24 Albumin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Albumin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 26 Blood urea nitrogen estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Blood urea market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 28 Uric acid market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Uric acid market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 30 Creatinine estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Creatinine market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 32 Sodium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Sodium market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 34 Potassium estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Potassium market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 36 Chloride market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Chloride market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 38 Calcium estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Calcium market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 40 Magnesium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 magnesium market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 42 Inorganic phosphorus estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Inorganic phosphorous market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 44 Aspartate transaminase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Aspartate transaminase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 46 Creatine kinase estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Creatine market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 48 Gamma glutamyl transferase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Gamma glutamyl market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 50 Total bilirubin estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Total bilirubin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 52 Glucose market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Glucose market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 54 C-reactive market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 C-reactive market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 56 Iron market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Iron market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 58 Alanine transaminase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Alanine transaminase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 60 Alkaline phosphatase estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Alkaline phosphatase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 62 Alpha amylase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Alpha amylase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 64 Total cholesterol market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Total cholesterol market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 66 Triglyceride estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Triglyceride market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 68 Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 70 Immunoglobulin G estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Immunoglobulin G market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 72 Immunoglobulin A market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Immunoglobulin A market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 74 Immunoglobulin M market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Immunoglobulin M market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 76 Complement 3market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Complement 3 market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 78 Complement 4 estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Complement 4 market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 80 Rheumatoid factor market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Rheumatoid factor market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 82 Anti-streptolysin -O market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Anti-streptolysin -O market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 84 Beta 2 microglobulin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Beta 2 microglobulin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 86 Cystatin-C market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Cystatin-C market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 88 Myoglobin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Myoglobin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 90 Troponin T and I market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Troponin T and I market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 92 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Others market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 94 Calibrators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Calibrators market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 96 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Others market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 98 In vitro diagnostics quality control market: type movement analysis
  • Fig. 99 In vitro diagnostics quality control market: type outlook and key takeaways
  • Fig. 100 Quality controls market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 101 Quality controls assurance services estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Plasma-based control market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Plasma-based control market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 104 Serum-based control estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Serum-based control market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 106 Whole blood-based control market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Whole blood-based control market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 108 Others estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 Others estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 110 Quality assurance services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 Data management solutions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 In vitro diagnostics quality control market: Application movement analysis
  • Fig. 113 In vitro diagnostics quality control market: Application outlook and key takeaways
  • Fig. 114 Immunochemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 Immunochemistry market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 116 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 117 Hematology market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 118 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 119 Clinical chemistry market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 120 Alkaline phosphatase (ALP) Molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 121 Alkaline phosphatase (ALP) market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 122 Alanine transaminase (ALT) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 123 Alanine transaminase (ALT) market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 124 Aspartate transaminase (AST) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Aspartate transaminase (AST) phosphatase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 126 Creatine kinase MB (CK-MB) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 127 Creatine kinase MB (CK-MB) market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 128 Albumin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 129 Albumin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 130 Creatinine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 131 Creatinine market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 132 Glucose market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 133 Glucose market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 134 Triglycerides market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 135 Triglycerides market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 136 Amylase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 137 Amylase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 138 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 139 Others market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 140 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 141 Molecular diagnostics market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 142 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 143 Coagulation market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 144 Microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 145 Microbiology market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 146 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 147 Others market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 148 In vitro diagnostics quality control market: Manufacturer type movement Analysis
  • Fig. 149 In vitro diagnostics quality control market: Manufacturer type outlook and key takeaways
  • Fig. 150 Third-party controls market estimates and forecasts, 2018 - 2030
  • Fig. 151 Independent controls market estimates and forecasts, 2018 - 2030
  • Fig. 152 Instrument specific controls market estimates and forecasts,2018 - 2030
  • Fig. 153 OEM controls market estimates and forecasts,2018 - 2030
  • Fig. 154 In vitro diagnostics quality control market: End-use movement Analysis
  • Fig. 155 In vitro diagnostics quality control market: End-use outlook and key takeaways
  • Fig. 156 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 157 Laboratories market estimates and forecasts,2018 - 2030
  • Fig. 158 Home Care market estimates and forecasts, 2018 - 2030
  • Fig. 159 Others market estimates and forecasts,2018 - 2030
  • Fig. 160 In-vitro diagnostics quality control market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 161 Regional marketplace: key takeaways
  • Fig. 162 Regional marketplace: key takeaways
  • Fig. 163 North America in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 164 Key country dynamics
  • Fig. 165 U.S. in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 166 Key country dynamics
  • Fig. 167 Canada in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 168 Europe in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 169 Key country dynamics
  • Fig. 170 UK in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 171 Key country dynamics
  • Fig. 172 Germany in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 173 Key country dynamics
  • Fig. 174 France in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 175 Key country dynamics
  • Fig. 176 Italy in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 177 Key country dynamics
  • Fig. 178 Spain in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 179 Key country dynamics
  • Fig. 180 Denmark in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 181 Key country dynamics
  • Fig. 182 Sweden in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 183 Key country dynamics
  • Fig. 184 Norway in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 185 Rest of Europe in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 186 Asia Pacific in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 187 Key country dynamics
  • Fig. 188 Japan in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 189 Key country dynamics
  • Fig. 190 China in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 191 Key country dynamics
  • Fig. 192 India in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 193 Key country dynamics
  • Fig. 194 Australia vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 195 Key country dynamics
  • Fig. 196 Thailand in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 197 Key country dynamics
  • Fig. 198 South Korea in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 199 Rest of Asia Pacific in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 200 Latin America in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 201 Key country dynamics
  • Fig. 202 Brazil in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 203 Key country dynamics
  • Fig. 204 Mexico in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 205 Key country dynamics
  • Fig. 206 Argentina in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 207 Rest of Latin America in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 208 MEA in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 209 Key country dynamics
  • Fig. 210 South Africa in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 211 Key country dynamics
  • Fig. 212 Saudi Arabia in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 213 Key country dynamics
  • Fig. 214 UAE in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 215 Key country dynamics
  • Fig. 216 Kuwait in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 217 Rest of MEA in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 218 Key company categorization
  • Fig. 219 In vitro diagnostics quality control market share analysis, 2023
  • Fig. 220 Company market share, 2023 for plasma-based controls
  • Fig. 221 Company market share, 2023 for serum-based controls
  • Fig. 222 Company market share, 2023 for whole blood-based controls
  • Fig. 223 Strategy mapping